首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.
【24h】

Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.

机译:三环环烷基咪唑基,嘧啶基和二氮杂庚啶二烯二酮的合成和生物活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Syntheses and physicochemical properties of N-cycloalkyl-substituted imidazo-, pyrimido- and 1,3-diazepino[2,1-f]purinediones are described. These derivatives were synthesized by cyclization of 7-halogenoalkyl-8-bromo-1,3-dimethylxanthine derivatives with aminocycloalkanes. The obtained compounds (1-33) were evaluated for their affinity to rat adenosine A(1) and A(2A) receptors. Selected compounds were additionally investigated for affinity to the human A(1), A(2A), A(2B) and A(3) receptor subtypes. The results of the radioligand binding assays at adenosine A(1) and A(2A) receptors showed that most of the compounds exhibited adenosine A(2A) receptor affinity at micromolar or submicromolar concentrations; an annelated pyrimidine ring was beneficial for A(2A) affinity. The most potent A(2A) ligands of the present series were compounds 6 (K(i) 0.33 muM rat A(2A), 0.31 muM human A(2A)), 8 (K(i) 0.98 muM rat A(2A), 0.42 muM human A(2A)) and 15 (K(i) 0.24 muM rat A(2A), 0.61 muM human A(2A)) with the latter one showing high A(2A) selectivity. In NaCl shift assay, 15 was shown to be an antagonist at A(2A) receptors. This result was confirmed for the best compounds 6, 8, 15 in cAMP accumulation studies. A 3D-QSAR equation with a good predicting power (q(2) = 0.88) for A(2A) AR affinity was obtained. The compounds were evaluated in vivo as anticonvulsants in MES and ScMet tests and examined for neurotoxicity in mice (i.p.). Most of them showed anticonvulsant activity in chemically induced seizures; among them the diazepinopurinediones were the best (e.g. 31) showing protection in both tests on short time symptoms, without signs of neurotoxicity. Five compounds, 8, 17, 20, 29, and 31, exhibited anticonvulsant activity after peroral application in rats. Structure-activity relationships are discussed including the analysis of lipophilic and spatial properties. The new compounds, which contain a basic nitrogen atom and can therefore be protonated, may be good starting points for obtaining A(2A) antagonists with good water-solubility.
机译:描述了N-环烷基取代的咪唑基,嘧啶基和1,3-二氮杂[2,1-f]嘌呤二酮的合成及其理化性质。这些衍生物是通过7-卤代烷基-8-溴-1,3-二甲基黄嘌呤衍生物与氨基环烷烃的环化反应合成的。评价获得的化合物(1-33)对大鼠腺苷A(1)和A(2A)受体的亲和力。还研究了所选化合物对人A(1),A(2A),A(2B)和A(3)受体亚型的亲和力。腺苷A(1)和A(2A)受体的放射性配体结合测定结果表明,大多数化合物在微摩尔或亚微摩尔浓度下均表现出腺苷A(2A)受体亲和力。退火的嘧啶环有利于A(2A)亲和力。本系列中最有效的A(2A)配体是化合物6(K(i)0.33μM大鼠A(2A),0.31μM人类A(2A)),8(K(i)0.98μM大鼠A(2A) ,0.42μM人类A(2A)和15(K(i)0.24μM大鼠A(2A),0.61μM人类A(2A)),后者显示出较高的A(2A)选择性。在NaCl迁移分析中,有15个是A(2A)受体的拮抗剂。在cAMP积累研究中,最好的化合物6、8、15证实了这一结果。获得了具有良好的A(2A)AR亲和力预测能力(q(2)= 0.88)的3D-QSAR方程。在MES和ScMet试验中,将这些化合物作为抗惊厥药进行了体内评估,并在小鼠(i.p.)中检查了其神经毒性。他们中的大多数在化学诱导的癫痫发作中表现出抗惊厥活性。其中,二氮杂pin啶二酮是最好的(例如31种),在两种试验中均显示出对短期症状的保护作用,而没有神经毒性的迹象。在大鼠经口施用后,有5种化合物8、17、20、29和31显示出抗惊厥活性。讨论了构效关系,包括亲脂性和空间性质的分析。含有碱性氮原子并因此可以质子化的新化合物可能是获得具有良好水溶性的A(2A)拮抗剂的良好起点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号